AMPOULES NOUVELLE GENERATION HEPATO
Food supplement declared in France, declaration No 2017-2-474
AMPOULES NOUVELLE GENERATION HEPATO (DIET HORIZON) is a food supplement declared in France. Status: retiré du marché (date non précisée dans Compl'Alim). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- DIET HORIZON
- Food business operator placing the product on the market
- Santé verte
- Status
- Retiré du marché (date non précisée dans Compl'Alim)
- Form
- Ampoule
- Daily dose
- 1 ampoule par jour
- Directions for use
- Prendre 1 ampoule par jour
- Not recommended for (according to the manufacturer)
- Insuffisance rénale, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Détoxifiant / Draineur
Declaration 337241, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché (date non précisée dans Compl'Alim), according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Cynara cardunculus L. | Capitule | Extrait fluide aqueux | 3,008 mg |
| Desmodium adscendens (Sw.) DC. | Feuille | Extrait fluide aqueux | 3,008 mg |
| Taraxacum campylodes G.E.Haglund | Racine | Extrait fluide aqueux | 1,203 mg |
| Raphanus raphanistrum subsp. sativus (L.) Domin | Racine | Pression à froid | 1,000 mg |
| Rosmarinus officinalis L. | Sommités fleuries | Hydrolât (eau florale) | 200 mg |
| Citrus limon (L.) Burm. f. | Fruit | Pression à froid | 40 mg |
| Fraxinus excelsior L. | Feuille (bourgeon) | Autre macérât | 10 mg |
| Juglans regia L. | Bourgeon | Autre macérât | 10 mg |
| Juniperus communis L. | Jeune pousse | Autre macérât | 10 mg |
| Rosmarinus officinalis L. | Jeune pousse | Autre macérât | 10 mg |
Additives
E422
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Femmes enceintes ou allaitantes, demandez conseil à votre médecin. Ne pas utiliser en cas d'insuffisance rénale, ne pas utiliser de manière prolongée (maximum 6 semaines). Une consommation excessive peut avoir des effets laxatifs.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Cynara cardunculus L.
Read the warning, when it applies and the studies cited
Globe Artichoke - Cynara Cardunculus
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones (Brinker 2010; Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Digestive disturbance/dyspepsia/Help increase bile flow.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you have a bile duct obstruction (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Taraxacum campylodes G.E.Haglund
Read the warning, when it applies and the studies cited
DANDELION - TARAXACUM OFFICINALE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder or an intestinal obstruction (Brinker 2010; Godfrey et al. 2010; ESCOP 2003; Bradley 1992).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Constipation, Flushing of the urinary tract, Indigestion, and Loss of appetite.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Applies to products providing 10 g or more of dried leaf or dried root or dried whole plant, per day or 10 mL or more of juice, per day.
Do not use if you have diabetes or a blood pressure, kidney or cardiovascular disorder (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking heart medications or other products containing diuretics (Goksu et al. 2010; EMA 2009; Hunt et al. 2005; Green et al. 2002; Mujais and Katz 2000; Carlsen et al. 1990; Kuller et al. 1986; Artz et al. 1966).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Rosmarinus officinalis L.
Read the warning, when it applies and the studies cited
ROSEMARY – ROSMARINUS OFFICINALIS Oral
Route of administration: Oral (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Contraindications
Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 May 2026
ROSEMARY - ROSMARINUS OFFICINALIS Topical
Route of administration: Topical (ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Juniperus communis L.
Read the warning, when it applies and the studies cited
Juniper - Juniperus Communis
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- AMPOULES NOUVELLE GENERATION HEPATO DIET HORIZON, declared in 2019, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
- AMPOULES NOUVELLE GENERATION HEPATO DIET HORIZON, declared in 2017, withdrawn from the market : different composition: 2 ingredient(s) added, 2 missing
Brand : DIET HORIZON
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.